agilon health (NYSE:AGL) Downgraded by Bank of America to “Underperform”

Bank of America lowered shares of agilon health (NYSE:AGL) from a buy rating to an underperform rating in a research report sent to investors on Wednesday morning, Marketbeat reports. The firm currently has $3.00 price objective on the stock.

Several other research firms have also commented on AGL. Benchmark reaffirmed a buy rating and set a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Royal Bank of Canada reaffirmed an outperform rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Evercore ISI upped their price target on shares of agilon health from $5.50 to $7.00 and gave the company an in-line rating in a research report on Tuesday, July 9th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of agilon health from $5.00 to $4.00 and set a hold rating for the company in a research report on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of Hold and an average target price of $8.22.

agilon health Price Performance

AGL opened at $3.21 on Wednesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The stock has a market capitalization of $1.32 billion, a P/E ratio of -4.59 and a beta of 0.54. The company’s 50-day simple moving average is $4.57 and its two-hundred day simple moving average is $5.40. agilon health has a 52-week low of $3.04 and a 52-week high of $20.37.

agilon health (NYSE:AGL) last posted its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). The business had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business’s revenue for the quarter was up 38.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.04) EPS. As a group, analysts predict that agilon health will post -0.32 EPS for the current year.

Insider Buying and Selling

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AGL. Capital International Investors boosted its stake in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the period. Capital World Investors boosted its stake in agilon health by 7.4% in the 4th quarter. Capital World Investors now owns 55,218,496 shares of the company’s stock worth $692,992,000 after purchasing an additional 3,813,214 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of agilon health by 46.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,139,886 shares of the company’s stock valued at $127,256,000 after acquiring an additional 3,195,087 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after acquiring an additional 1,191,253 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.